Aelis Farma (FRA:69O) Accounts Payable: €0.51 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:69O Aelis Farma SA FRA:69O
32 GF Score
Price €1.00
GF Value €0.95
! 4 Warning Signs
View Full Analysis

What is Aelis Farma Accounts Payable?

Aelis Farma FRA:69O +1.52% 32 Accounts Payable is €0.51 Mil as of Dec. 2025. GuruFocus rates FRA:69O with a GF Score™ of 32/100 and a GF Value™ of €0.95. The stock has 4 warning signs investors should review.

Aelis Farma's Accounts Payable for the quarter that ended in Dec. 2025 was €0.51 Mil.

Aelis Farma's quarterly Accounts Payable declined from Dec. 2024 (€1.18 Mil) to Jun. 2025 (€1.03 Mil) and declined from Jun. 2025 (€1.03 Mil) to Dec. 2025 (€0.51 Mil).

Aelis Farma's annual Accounts Payable declined from Dec. 2023 (€4.50 Mil) to Dec. 2024 (€1.18 Mil) and declined from Dec. 2024 (€1.18 Mil) to Dec. 2025 (€0.51 Mil).

Aelis Farma Accounts Payable Historical Data

* Premium members only.

The historical data trend for Aelis Farma's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aelis Farma Accounts Payable Chart

Aelis Farma Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Accounts Payable
Get a 7-Day Free Trial Premium Member Only 2.24 2.42 4.50 1.18 0.51

Aelis Farma Semi-Annual Data
Dec17 Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.50 3.40 1.18 1.03 0.51
FRA:69O
32GF Score
Aelis Farma SA FRA:69O
Accounts Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Aelis Farma Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Frequently Asked Questions Learn more about Accounts Payable →
What does a Accounts Payable of €0.51 Mil mean?
Aelis Farma (FRA:69O) has a Accounts Payable of €0.51 Mil as of Dec. 2025. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Aelis Farma and its competitors.
Is Aelis Farma's Accounts Payable too high?
Aelis Farma's current Accounts Payable is €0.51 Mil. Overall, Aelis Farma has a GF Score™ of 32/100, reflecting its overall financial health beyond just this single metric.
How does Aelis Farma's Accounts Payable compare to VRTX and REGN?
Aelis Farma's Accounts Payable of €0.51 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable for a Biotechnology company?
A good Accounts Payable depends on the Biotechnology industry context. However, Accounts Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable mean?
A high Accounts Payable can signal that a stock is expensive relative to its fundamentals. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Aelis Farma and its competitors. Aelis Farma's current Accounts Payable is €0.51 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aelis Farma stock overvalued right now?
Aelis Farma (FRA:69O) has a current Accounts Payable of €0.51 Mil. The stock's GF Value™ is €0.95, compared to a current price of €1.00 — trading 5.3% above its estimated fair value. The current Accounts Payable is €0.51 Mil. Aelis Farma's overall GF Score™ is 32/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable calculated?
Accounts Payable is calculated from a company's financial statements. For Aelis Farma (FRA:69O), the current Accounts Payable is €0.51 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Aelis Farma (FRA:69O) Overvalued in 2026?

Based on GuruFocus' analysis, Aelis Farma stock appears to be overvalued. The current stock price of €1.00 is trading 5.3% above its estimated GF Value™ of €0.95.

Key valuation signals for FRA:69O:

  • Accounts Payable: €0.51 Mil
  • GF Value™: €0.95 vs. price of €1.00 (5.3% above fair value)
  • GF Score™: 32/100 with 4 warning signs

No single metric tells the full story. See the FRA:69O stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Aelis Farma Business Description

Other Exchanges AELIS:France
Address 2 rue Robert Escarpit, IECB, Pessac, Bordeaux, FRA, 33607
Aelis Farma SA is a biotechnology Company specializing in the research and development of treatment's related to brain diseases. The Company operates in only one business segment: the research and development of pharmaceutical products.
32GF Score

Get the complete analysis for FRA:69O

Accounts Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.00
Price
€0.95
GF Value